Lapatinib
Lapatinib comes in 3 pill versions in our database, in 1 strength, from 3 manufacturers. Check the imprint to tell them apart.
Lapatinib pill images
250 mg 3 pills
What is Lapatinib used for?
Lapatinib is used for breast cancer.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
TYKERB® is indicated in combination with:
- capecitabine for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress human epidermal growth factor receptor 2 (HER2) and who have received prior therapy, including an anthracycline, a taxane, and trastuzumab. Limitations of Use: Patients should have disease progression on trastuzumab prior to initiation of treatment with TYKERB in combination with capecitabine.
- letrozole for the treatment of postmenopausal women with hormone receptor-positive metastatic breast cancer that overexpresses the HER2 receptor for whom hormonal therapy is indicated.
TYKERB in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.
From the FDA-approved label on DailyMed (published Jan 28, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.